Does TEPROTUMUMAB-TRBW Cause Red cell distribution width increased? 9 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Red cell distribution width increased have been filed in association with TEPROTUMUMAB-TRBW. This represents 0.2% of all adverse event reports for TEPROTUMUMAB-TRBW.
9
Reports of Red cell distribution width increased with TEPROTUMUMAB-TRBW
0.2%
of all TEPROTUMUMAB-TRBW reports
0
Deaths
2
Hospitalizations
How Dangerous Is Red cell distribution width increased From TEPROTUMUMAB-TRBW?
Of the 9 reports, 2 (22.2%) required hospitalization.
Is Red cell distribution width increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TEPROTUMUMAB-TRBW. However, 9 reports have been filed with the FAERS database.
What Other Side Effects Does TEPROTUMUMAB-TRBW Cause?
Muscle spasms (998)
Fatigue (704)
Tinnitus (524)
Headache (443)
Hypoacusis (430)
Diarrhoea (408)
Nausea (407)
Blood glucose increased (401)
Alopecia (390)
Pain (344)
What Other Drugs Cause Red cell distribution width increased?
CLOZAPINE (439)
METHOTREXATE (210)
ALEMTUZUMAB (202)
RITUXIMAB (198)
PREDNISONE (178)
PALBOCICLIB (171)
ADALIMUMAB (144)
METHYLPREDNISOLONE (123)
ECULIZUMAB (110)
TOCILIZUMAB (108)
Which TEPROTUMUMAB-TRBW Alternatives Have Lower Red cell distribution width increased Risk?
TEPROTUMUMAB-TRBW vs TERAZOSIN
TEPROTUMUMAB-TRBW vs TERAZOSIN\TERAZOSIN
TEPROTUMUMAB-TRBW vs TERBINAFINE
TEPROTUMUMAB-TRBW vs TERBINAFINE\TERBINAFINE
TEPROTUMUMAB-TRBW vs TERBUTALINE